Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease

被引:1
|
作者
Vrancken, Anniek [1 ]
De langhe, Ellen [2 ]
Westhovens, Rene [2 ]
Yserbyt, Jonas [1 ]
Cottin, Vincent [3 ]
Wuyts, Wim [1 ]
机构
[1] Univ Hosp Leuven, Dept Pneumol, Leuven, Belgium
[2] Univ Hosp Leuven, Dept Rheumatol, Leuven, Belgium
[3] Univ Lyon, Claude Bernard Lyon 1, Hosp Louis Pradel, Dept Pneumol, Lyon, France
来源
RESPIROLOGY CASE REPORTS | 2015年 / 3卷 / 03期
关键词
Connective tissue disease; interstitial lung disease; systemic sclerosis; undifferentiated connective tissue disease;
D O I
10.1002/rcr2.113
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
We discuss a case that demonstrates the difficulties in making a confident diagnosis of interstitial lung disease (ILD) associated with systemic sclerosis (SSc). Atypical symptoms can be present, suggesting the diagnosis of an underlying connective tissue disease (CTD), but it can take several years before a definite diagnosis can be made because there are insufficient features to fulfill the preset classification criteria (American College of Rheumatology criteria) for a definite underlying CTD. Close follow-up of these patients is necessary because patients with SSc-ILD have a poorer prognosis than those with SSc without pulmonary involvement. Treatment choice also differs between idiopathic ILD and SScrelated ILD.
引用
收藏
页码:99 / 101
页数:3
相关论文
共 50 条
  • [1] Systemic Sclerosis-Related Interstitial Lung Disease
    Dalal, Samay
    Fischer, Aryeh
    Swigris, Jeffrey J.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2008, 4 (03) : 226 - 232
  • [2] Detection and classification of systemic sclerosis-related interstitial lung disease: a review
    DeMizio, Daniel J.
    Bernstein, Elana J.
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (06) : 553 - 560
  • [3] Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease
    Robert L. Mango
    Eric L. Matteson
    Cynthia S. Crowson
    Jay H. Ryu
    Ashima Makol
    Lung, 2018, 196 : 409 - 416
  • [4] Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease
    Mango, Robert L.
    Matteson, Eric L.
    Crowson, Cynthia S.
    Ryu, Jay H.
    Makol, Ashima
    LUNG, 2018, 196 (04) : 409 - 416
  • [5] Update on morbidity and mortality in systemic sclerosis-related interstitial lung disease
    Volkmann, Elizabeth R.
    Fischer, Aryeh
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2021, 6 (01) : 11 - 20
  • [6] Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease—a randomised controlled trial
    Nupoor Acharya
    Shefali Khanna Sharma
    Debashish Mishra
    Sahajal Dhooria
    Varun Dhir
    Sanjay Jain
    Rheumatology International, 2020, 40 : 703 - 710
  • [7] Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
    Lee, Shih-Ching
    Huang, Chen-Hao
    Oyang, Yen-Jen
    Huang, Hsuan-Cheng
    Juan, Hsueh-Fen
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [8] Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease-a randomised controlled trial
    Acharya, Nupoor
    Sharma, Shefali Khanna
    Mishra, Debashish
    Dhooria, Sahajal
    Dhir, Varun
    Jain, Sanjay
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (05) : 703 - 710
  • [9] Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Sim, Myung
    Li, Ning
    Khanna, Dinesh
    Roth, Michael D.
    Clements, Philip J.
    Hoffmann-Vold, Anna-Maria
    Furst, Daniel E.
    Kim, Grace
    Goldin, Jonathan
    Elashoff, Robert M.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (10) : 1316 - 1325
  • [10] Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease
    Neslihan Yilmaz
    Yasin Abul
    Muge Bicakcigil
    Pejman Golabi
    Cigdem Celikel
    Sait Karakurt
    Sule Yavuz
    Rheumatology International, 2012, 32 : 1921 - 1925